COVID-19 pandemic
Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of six months and 11 years, which is considered a crucial step towards vaccinating children.
Sources: CNBC
Changes
- Pfizer and BioNTech begins a clinical trial testing of its COVID-19 vaccine on healthy 6-month infants to 11-year-old children, which is a crucial step to vaccinating children.
- Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of 6 months and 11 years, which is a crucial step toward vaccinating children.
- Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of six months and 11 years, which is considered a crucial step towards vaccinating children.